KRT19 and hepatocellular carcinoma: As CK19 promotes angiogenesis and tumor cell invasiveness, CK19 positive HCC (CK19+HCC) is more malignant and has a worse prognosis than CK19 negative HCC (CK19-HCC) 13-17.